Metered dose inhaler for fluticasone propionate
Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas kn...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Ashurst, Ian C Britto, Ignatius Loy Herman, Craig Steven Li-Bovet, Li Riebe, Michael Thomas |
description | Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas known as a propellant. The suspension is stored in a sealed container capable of withstanding the pressure required to maintain the propellant as a liquid. The suspension is dispersed by activation of a dose metering valve affixed to the container.
A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06546928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06546928</sourcerecordid><originalsourceid>FETCH-uspatents_grants_065469283</originalsourceid><addsrcrecordid>eNrjZND3TS1JLUpNUUjJL05VyMzLSMxJLVJIywfinNKSzOTE4vy8VIWCovyCzPy8xJJUHgbWtMSc4lReKM3NoODmGuLsoVtaXACUzispjk8vSgRRBmamJmaWRhbGRCgBABybLC0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Metered dose inhaler for fluticasone propionate</title><source>USPTO Issued Patents</source><creator>Ashurst, Ian C ; Britto, Ignatius Loy ; Herman, Craig Steven ; Li-Bovet, Li ; Riebe, Michael Thomas</creator><creatorcontrib>Ashurst, Ian C ; Britto, Ignatius Loy ; Herman, Craig Steven ; Li-Bovet, Li ; Riebe, Michael Thomas ; SmithKline Beecham Corporation</creatorcontrib><description>Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas known as a propellant. The suspension is stored in a sealed container capable of withstanding the pressure required to maintain the propellant as a liquid. The suspension is dispersed by activation of a dose metering valve affixed to the container.
A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6546928$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6546928$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ashurst, Ian C</creatorcontrib><creatorcontrib>Britto, Ignatius Loy</creatorcontrib><creatorcontrib>Herman, Craig Steven</creatorcontrib><creatorcontrib>Li-Bovet, Li</creatorcontrib><creatorcontrib>Riebe, Michael Thomas</creatorcontrib><creatorcontrib>SmithKline Beecham Corporation</creatorcontrib><title>Metered dose inhaler for fluticasone propionate</title><description>Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas known as a propellant. The suspension is stored in a sealed container capable of withstanding the pressure required to maintain the propellant as a liquid. The suspension is dispersed by activation of a dose metering valve affixed to the container.
A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZND3TS1JLUpNUUjJL05VyMzLSMxJLVJIywfinNKSzOTE4vy8VIWCovyCzPy8xJJUHgbWtMSc4lReKM3NoODmGuLsoVtaXACUzispjk8vSgRRBmamJmaWRhbGRCgBABybLC0</recordid><startdate>20030415</startdate><enddate>20030415</enddate><creator>Ashurst, Ian C</creator><creator>Britto, Ignatius Loy</creator><creator>Herman, Craig Steven</creator><creator>Li-Bovet, Li</creator><creator>Riebe, Michael Thomas</creator><scope>EFH</scope></search><sort><creationdate>20030415</creationdate><title>Metered dose inhaler for fluticasone propionate</title><author>Ashurst, Ian C ; Britto, Ignatius Loy ; Herman, Craig Steven ; Li-Bovet, Li ; Riebe, Michael Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_065469283</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ashurst, Ian C</creatorcontrib><creatorcontrib>Britto, Ignatius Loy</creatorcontrib><creatorcontrib>Herman, Craig Steven</creatorcontrib><creatorcontrib>Li-Bovet, Li</creatorcontrib><creatorcontrib>Riebe, Michael Thomas</creatorcontrib><creatorcontrib>SmithKline Beecham Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ashurst, Ian C</au><au>Britto, Ignatius Loy</au><au>Herman, Craig Steven</au><au>Li-Bovet, Li</au><au>Riebe, Michael Thomas</au><aucorp>SmithKline Beecham Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Metered dose inhaler for fluticasone propionate</title><date>2003-04-15</date><risdate>2003</risdate><abstract>Drugs for treating respiratory and nasal disorders are frequently administered in aerosol formulations through the mouth or nose. One widely used method for dispensing such aerosol drug formulations involves making a suspension formulation of the drug as a finely divided powder in a liquefied gas known as a propellant. The suspension is stored in a sealed container capable of withstanding the pressure required to maintain the propellant as a liquid. The suspension is dispersed by activation of a dose metering valve affixed to the container.
A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_06546928 |
source | USPTO Issued Patents |
title | Metered dose inhaler for fluticasone propionate |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ashurst,%20Ian%20C&rft.aucorp=SmithKline%20Beecham%20Corporation&rft.date=2003-04-15&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06546928%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |